AKT1 and T-cell acute lymphoblastic leukemia: For instance, ginsenoside Rh2 has been demonstrated to promote cell apoptosis in T-cell acute lymphocytic leukemia through the regulation of the MAPK and PI3K/AKT signaling pathways [47].